A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group (Q39432410)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group |
scientific article |
Statements
1 reference
A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group (English)
1 reference
Savani N
1 reference
Brautaset NJ
1 reference
Reunanen M
1 reference
Szirmai I
1 reference
Ashford EA
1 reference
Hassani H
1 reference
Saiers J
1 reference
1 August 1999
1 reference
1 reference
105
1 reference
7-15
1 reference
Identifiers
1 reference